News

IV: Industrie: Österreichische Umwelttechnologie stärken – Plastikproblem global lösen

V-VGS Koren: Plastik in Umwelt nicht akzeptabel – Deponieverbot von Kunststoffen in der EU durchsetzen – Heimische...

FCIO: Kunststoffindustrie zu Plastik-Gipfel: Umweltnutzen von geplanten Plastikverboten fragwürdig

Alternative Materialien haben meist einen schlechteren Klimafußabdruck

MedUni Vienna: The biomechanics of vascular aging

Cardiovascular Diseases (CVD) lead to atherosclerosis and heart failure and are prevalent age-related illnesses in...

Valneva Announces its Intention to Delist from the Vienna Stock Exchange

Trading will be centralized on Euronext Paris

Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate

Phase 1 interim results showed an excellent immunogenicity profile after a single-shot vaccination and an acceptable...

AOP Orphan Pharmaceuticals AG and Chord Therapeutics Announce a Partnership to Develop CRD1 (Cladribine) for Treatment of Orphan Autoimmune Diseases

AOP Orphan Pharmaceuticals AG (AOP Orphan) and Chord Therapeutics (Chord) step into a new partnership to develop CRD1...

Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead

HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapies targeting infectious diseases and...

Marinomed: Screening of pivotal clinical trial completed

Marinomed Biotech AG and the Vienna Challenge Chamber are happy to report the successful screening and completed...

Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate

Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major...